GRC
GRC is Egypt’s premier full-service contract research organization (CRO), established in 2007. It specializes in bioequivalence, biowaivers, clinical trials (Phases II–IV), stability studies, and pharmacovigilance. As an industry leader, GRC offers comprehensive research services within a single facility, ensuring excellence and regulatory compliance throughout each stage of drug development. The company aims to advance healthcare innovations through high-quality clinical trials, scientific expertise, and regulatory support, supporting the development of therapies and improving patient outcomes.
Industries
Nr. of Employees
small (1-50)
GRC
50 El-Khalifa El-Maamoun , Heliopolis.11757 Cairo, Egypt
Services
Full-service BE/BA study planning and execution to demonstrate pharmaceutical equivalence between generics and reference products for regulatory registration.
Analytical method development, validation, transfer and sample analysis for clinical PK and BE studies using chromatographic and mass-spectrometry techniques.
On-site clinical unit with participant accommodation, emergency facilities, controlled pharmacy and volunteer pool support for conducting clinical studies.
PK/PD analyses, sample size calculations, statistical planning and data interpretation to support study design and regulatory submissions.
Dissolution testing and in‑vitro assays for solid oral dosage forms and suspensions following regulatory guidance to assess formulation performance.
Investigator and site identification, recruitment and retention strategies tailored to study requirements and target populations.
Full-service BE/BA study planning and execution to demonstrate pharmaceutical equivalence between generics and reference products for regulatory registration.
Analytical method development, validation, transfer and sample analysis for clinical PK and BE studies using chromatographic and mass-spectrometry techniques.
On-site clinical unit with participant accommodation, emergency facilities, controlled pharmacy and volunteer pool support for conducting clinical studies.
PK/PD analyses, sample size calculations, statistical planning and data interpretation to support study design and regulatory submissions.
Dissolution testing and in‑vitro assays for solid oral dosage forms and suspensions following regulatory guidance to assess formulation performance.
Investigator and site identification, recruitment and retention strategies tailored to study requirements and target populations.
Expertise Areas
- Bioequivalence and bioavailability studies
- Clinical trial management (Phases II–IV)
- Bioanalytical chemistry and LC–MS/MS assays
- Pharmacokinetics and biostatistics
Key Technologies
- Liquid chromatography–tandem mass spectrometry (LC–MS/MS)
- Ultra-performance liquid chromatography (UPLC)
- High-performance liquid chromatography (HPLC)
- EDC and clinical database systems
News & Updates
Join us in advancing scientific knowledge through collaborative research, fostering innovation, discovery, and progress for a brighter future.
Discuss the crucial role of in-vitro studies in the early stages of drug development, focusing on their ability to predict drug behavior and identify potential issues before clinical trials.
Join us in advancing scientific knowledge through collaborative research, fostering innovation, discovery, and progress for a brighter future.
Discuss the crucial role of in-vitro studies in the early stages of drug development, focusing on their ability to predict drug behavior and identify potential issues before clinical trials.